3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2012 Results

SHENYANG, China, March 3, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited fourth quarter and full year 2012 results on Tuesday, March 19, 2013 at 8:00am China Standard Time.

Following the earnings announcement, 3SBio's senior management will host a conference call on Tuesday, March 19, 2013 8:00pm China Standard Time (8:00am US Eastern or 5:00am US Pacific) to discuss its unaudited fourth quarter and full year 2012 results and recent business activity. The conference call may be accessed using the dial-in numbers below:

Conference ID: 15890708

Local dial-in:
China landline: 800-819-0121
China mobile: 400-620-8038
Hong Kong : 852-2475-0994
United States: 718-354-1231

International toll-free dial-in:
Hong Kong: 800930346
United States: 1-866-519-4004
United Kingdom: 080-8234-6646

International toll dial-in: 65 6723 9381

Replay- Conference ID: 15890708
A telephone replay will be available two hours after the call until March 27, 2013 at:
International: 61-2-8235-5000
United States: 1-866-214-5335

Webcast
A live webcast of the conference will be available on the investor relations section of 3SBio's website at www.3sbio.com and at http://www.media-server.com/m/p/bcshv7v5.

A replay of the webcast will be available within one hour after the conclusion of the call.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.


Investor Contacts


Bo Tan

Tom Folinsbee

Chief Financial Officer

Director of Investor Relations

3SBio Inc.

3SBio Inc.

Tel: + 86 24 2581-1820

Tel: + 852 8191-6991 

ir@3SBio.com

ir@3SBio.com

SOURCE 3SBio Inc.



RELATED LINKS
http://www.3sbio.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.